Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05818878

RSA Masterloc Study Australia

Prospective, Multicentric Study to Assess Stability of a Tapered Porous Coated Stem and a Cementless Hemispherical Acetabular Component

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
26 (estimated)
Sponsor
Medacta International SA · Industry
Sex
All
Age
70 Years
Healthy volunteers

Summary

This is a prospective, multicentric study that aim to assess stability of a tapered porous coated stem and a cementless hemispherical acetabular component. Main Translation and rotation around the x., y-, and z-axis of the femoral and cup component by radiostereometric analysis (RSA) at immediate post op (within 5 days and before weight bearing), 6 months, 1year and 2 years

Detailed description

Aim of this study is to assess stem and cup migration over the time in patient subjected to a total hip arthroplasty. Medical Device Research Australia will perform image analysis services and reporting for model based radiostereometric analysis (RSA) of cementless fixation of the femoral and acetabular cup components. Migration of the components will be measured with model-based RSA (MBRSA) at immediate post op (within 5 days and before weight bearing), 6 months, 1year and 2 years A subgroup of 26 patients will be invited to be evaluated also by additional RSA analysis: the first 13 patients for each investigator who will accept. The results of this work will establish the mechanical stability of Masterloc femoral component (Medacta International SA) and MPACT acetabular component (Medacta International SA), provide a general estimate of survivorship, and establish clinical safety and efficacy as measured by RSA and clinical outcomes.

Conditions

Timeline

Start date
2020-09-01
Primary completion
2022-09-01
Completion
2025-11-01
First posted
2023-04-19
Last updated
2025-09-29

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT05818878. Inclusion in this directory is not an endorsement.

RSA Masterloc Study Australia (NCT05818878) · Clinical Trials Directory